Disitamab vedotin [2136633-23-1]

MedChem Express

Disitamab vedotin [2136633-23-1]

10

2136633-23-1

Research Use Only

Monoclonal

99.0

Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE) (HY-15162), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Disitamab vedotin enhances antitumor immunity[1].

-80°C

41116161